- 14 Mar 2016 Allan Bradley's path to Kymab
- 9 Mar 2016 Cambridge Business interviews Dave Chiswell
- 2 Feb 2016 Kymab Succeeds in Revoking Regeneron’s UK VelocImmune® Patents
- 7 Sep 2015 Kymab: biotech company that is ‘One to Watch’
- 6 May 2015 Kymab secures US$90 million funding
- 19 Feb 2015 Anne Hyland appointed Chief Financial Officer
- 9 Feb 2015 David Chiswell becomes Kymab interim CEO
- 16 Dec 2014 Partnership to fight Ebola virus
- 23 Sep 2014 New appointments strengthen Board
- 1 Sep 2014 Kymab profiled as Biopharma Dealmaker